Actelion Announces Half Year Financial Results 2006
20 juil. 2006 01h00 HE
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland, July 20, 2006 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced its financial results for the first six months of 2006. With total net revenue for H1 2006 of CHF...
Actelion and Roche Enter Into Autoimmune Disorder Collaboration
17 juil. 2006 01h30 HE
|
Actelion Ltd.
Co-development for Actelion's Selective S1P1 Receptor
Agonist in Multiple Indications With Co-promotion and Profit
Share -- Actelion to Receive Upfront Payment of US$75 Million --
...
Actelion/Merck Renin Alliance Achieves Third Milestone
06 juil. 2006 01h00 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, July 6, 2006 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today that the renin alliance with Merck & Co., Inc. (NYSE:MRK) has achieved its third...
Actelion: Preliminary Results of CONSCIOUS-1 -- Significant Reduction of Cerebral Vasospasm in Patients With Aneurysmal Subarachnoid Hemorrhage -- Primary Endpoint Achieved
19 juin 2006 01h00 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, June 19, 2006 (PRIMEZONE) -- Actelion Ltd. (Other OTC:ALIOF) (SWX:ATLN) announced today that preliminary analysis of the dose-finding study CONSCIOUS-1 (Clazosentan to Overcome...
Actelion: ATS Presentation Highlights Strong Rationale for a Morbidity/Mortality Study with Bosentan in Idiopathic Pulmonary Fibrosis
23 mai 2006 13h34 HE
|
Actelion Ltd.
SAN DIEGO, May 23, 2006 (PRIMEZONE) -- Actelion Ltd (Other OTC:ALIOF) (SWX:ATLN) announced today that data presented from the BUILD program (Bosentan Use in Interstitial Lung Disease) at the American...
Actelion Announces First Quarter Results 2006
20 avr. 2006 01h07 HE
|
Actelion Ltd.
ALLSCHWIL and BASEL, Switzerland, April 20, 2006 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) today announced its financial results for the first quarter of 2006. With total net revenue of CHF 210.6 million...
Actelion Ltd.: Annual General Meeting of Shareholders in Basel, Switzerland
10 avr. 2006 11h41 HE
|
Actelion Ltd.
ALLSCHWIL and BASEL, Switzerland, April 10, 2006 (PRIMEZONE) -- At today's Annual General Meeting of Actelion Ltd. (Other OTC:ALIOF) (SWX:ATLN) shareholders approved all resolutions.
Shareholders...
Actelion Announces Full Year 2005 Financial Results
23 févr. 2006 01h00 HE
|
Actelion Ltd.
-- Total net revenue up 41% to CHF 663.6 million
-- Tracleer(r) sales up 41 % to CHF 633.2 million
-- Operating income up 78% to CHF 152.3 million
-- Net income of CHF 125.5 million
--...
Actelion Ltd.: Bosentan Studies In Pulmonary Fibrosis Show No Effect On Primary Exercise Improvement Endpoint
28 nov. 2005 00h00 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland, Nov. 28, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) today announced that in the BUILD program with bosentan (Tracleer(R)) in patients suffering from either...
Actelion and UCB Enter Into Assignment and License Agreement for Zavesca -- miglustat
17 nov. 2005 01h00 HE
|
Actelion Ltd.
ALLSCHWIL, Switzerland and BRUSSELS, Belgium, Nov. 17, 2005 (PRIMEZONE) -- Actelion Ltd (SWX:ATLN) (Other OTC:ALIOF) and UCB (Euronext: UCB, UCBBt.RR, UCB BB) today announced that the two companies...